HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Freitag Selected Research

Cystic Fibrosis (Mucoviscidosis)

11/2015Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
2/2015Implementation of a cystic fibrosis lung transplant referral patient decision aid in routine clinical practice: an observational study.
11/2010Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
10/2009Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation.
10/2008Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).
9/2008Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients.
8/2005Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Freitag Research Topics

Disease

7Cystic Fibrosis (Mucoviscidosis)
11/2015 - 08/2005
6Critical Illness (Critically Ill)
07/2017 - 09/2003
3Hemorrhage
07/2017 - 01/2008
3Lung Diseases (Lung Disease)
02/2015 - 09/2003
3Renal Insufficiency (Renal Failure)
09/2008 - 12/2005
2Thrombocytopenia (Thrombopenia)
07/2017 - 10/2013
2Venous Thrombosis (Deep-Vein Thrombosis)
09/2008 - 12/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Thrombosis (Thrombus)
07/2017
1Anemia
07/2017
1Chronic Obstructive Pulmonary Disease (COPD)
01/2015
1Liver Diseases (Liver Disease)
10/2013
1Barotrauma
12/2011
1Infections
11/2010
1Pulmonary Embolism
01/2008
1Chronic Renal Insufficiency
01/2008
1Venous Thromboembolism
01/2008
1Thromboembolism
12/2005
1Pseudomonas Infections
09/2003

Drug/Important Bio-Agent (IBA)

3AnticoagulantsIBA
07/2017 - 01/2008
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2013 - 12/2005
2Anti-Bacterial Agents (Antibiotics)IBA
11/2015 - 08/2005
2Dalteparin (Dalteparin Sodium)FDA Link
09/2008 - 01/2008
2CreatinineIBA
09/2008 - 01/2008
2Pharmaceutical PreparationsIBA
09/2008 - 12/2005
1Biological ProductsIBA
08/2022
1bimekizumabIBA
08/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2011
1SteroidsIBA
12/2011
1Alendronate (Alendronate Sodium)FDA LinkGeneric
10/2008
1Factor Xa (Coagulation Factor Xa)IBA
01/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2008
1Insulin (Novolin)FDA Link
05/2004

Therapy/Procedure

5Lung Transplantation
02/2015 - 09/2003
4Therapeutics
01/2022 - 05/2004
1Platelet Transfusion (Blood Platelet Transfusions)
07/2017
1Noninvasive Ventilation
01/2015
1Renal Replacement Therapy (Therapies, Renal Replacement)
10/2013
1Chest Tubes (Chest Tube)
12/2011
1Contraindications
09/2008
1Critical Care (Surgical Intensive Care)
12/2005
1Artificial Respiration (Mechanical Ventilation)
09/2003